Hyaluronated nanoparticles deliver raloxifene to CD44-expressed colon cancer cells and regulate lncRNAs/miRNAs epigenetic cascade

Abstract Background Colorectal malignant cells (CRC) are one of the world’s main causes of cancer mortality and morbidity. Notwithstanding the plenty of anti-CRC therapeutics, its prognosis remains not selective owing to cancer resistance to these therapeutics. Raloxifene (RX), a medication firstly...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Ahmed A. Abd-Rabou, Ahmed M. Abdelaziz, Olfat G. Shaker, Ghada Ayeldeen
Formato:	Artigo
Idioma:	Inglês
Publicado em:	BMC 2023-04-01
Colecção:	Cancer Nanotechnology
Assuntos:	Raloxifene Hyaluronic acid lncRNA miRNA Colon cancer cells
Acesso em linha:	https://doi.org/10.1186/s12645-023-00183-w
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!